A Note on Therapeutic Equivalence and Therapeutic Ratio with Application to Studies in Respiratory Diseases
This paper argues that the concepts of therapeutic equivalence and noninferiority trials have some unclear logic and give results that might not be in accordance with clinical experience. They are also totally unnecessary. The discussion focuses on therapeutic equivalence trials, but carries over directly to noninferiority trials. Therapeutic equivalence proves to be a flexible tool for delusion and should be abandoned. Statistics should end where it can claim to be correct and useful, in this case, with estimates and confidence limits of clinically relevant parameters such as relative dose potency. If therapeutic equivalence is still needed for special purposes, the testing and definition should be done on the dose scale.
Key WordsTherapeutic equivalence Noninferiority trials Therapeutic ratio
Unable to display preview. Download preview PDF.
- 1.ICH Harmonised Tripartite Guideline. Statistical principles in clinical trials. Stat Med. 1999; 18:1905–1942.Google Scholar
- 3.FDC Reports, The pink sheets. May 6, 1991;53(18): 14-15.Google Scholar
- 7.Senn SJ. Statistical issues in Drug Development. Chichester: John Wiley; 1997.Google Scholar
- 8.Finney DJ. Statistical Methods in Biological Assay. London, UK: Griffin; 1978.Google Scholar
- 10.Senn SJ, et al. An incomplete blocks cross-over in asthma: a case study in collaboration. Cross-over Clinical Trials. J. Vollmar, L.A. Hothorn, eds. Stuttgart: Fischer; 1997:3–26.Google Scholar
- 14.Rott Z, Bocskei C, Poszi M, Juhasz G, Larsson P, Rosenborg J. On the relative therapeutic index between formoterol Turbuhaler and Salbutamol pressurized metered dose (pMDI) inhaler in asthmatic patients. Eur Respir J. 1998;12:suppl 28:324s.Google Scholar